Back
Adaptive Biotechnologies Corp. 10K Form
Buy
62
ADPT
Adaptive Biotechnologies Corp.
Last Price:
$17.46
Seasonality Move:
-8.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | ADPT/Adaptive Biotechnologies Corp. Quarterly |
| 2023-08-02 | 10Q | ADPT/Adaptive Biotechnologies Corp. Quarterly |
| 2023-05-03 | 10Q | ADPT/Adaptive Biotechnologies Corp. Quarterly |
| 2022-11-03 | 10Q | ADPT/Adaptive Biotechnologies Corp. Quarterly |
| 2022-08-03 | 10Q | ADPT/Adaptive Biotechnologies Corp. Quarterly |
| 2022-05-04 | 10Q | ADPT/Adaptive Biotechnologies Corp. Quarterly |
Receive ADPT News And Ratings
See the #1 stock for the next 7 days that we like better than ADPT
ADPT Financial Statistics
Sales & Book Value
| Annual Sales: | $179M |
|---|---|
| Cash Flow: | $-7.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.34 |
| Price / Book: | 13.04 |
Profitability
| EPS (TTM): | -0.53820 |
|---|---|
| Net Income (TTM): | $-79.6M |
| Gross Margin: | $96.6M |
| Return on Equity: | -39.8% |
| Return on Assets: | -15.33% |
Adaptive Biotechnologies Corp. Earnings Forecast
Key Adaptive Biotechnologies Corp. Financial Ratios
-
The Gross Profit Margin over the past 19 years for ADPT is 53.95%.
-
The Selling, General & Administrative Expenses for ADPT have been equal to 88.05% of Gross Profit Margin.
-
The Research & Development expenses have been 52.71% of Revenue.
-
The Net Earning history of ADPT is -89.18% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 6 years.
Adaptive Biotechnologies Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | ADPT |
| CUSIP: | 00650F |
| Website: | adaptivebiotech.com |
Debt
| Debt-to-Equity Ratio: | 1.05 |
|---|---|
| Current Ratio: | 3.38 |
| Quick Ratio: | 3.09 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ADPT Technical Analysis vs Fundamental Analysis
Buy
62
Adaptive Biotechnologies Corp. (ADPT)
is a Buy
Is Adaptive Biotechnologies Corp. a Buy or a Sell?
-
Adaptive Biotechnologies Corp. stock is rated a BuyThe current Adaptive Biotechnologies Corp. [ADPT] share price is $17.46. The Score for ADPT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.